ArticleJournal of medicinal chemistry2020

Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer.

Yali He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.